Alkem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 19-11-2024
- Paid Up Capital ₹ 23.91 Cr
as on 19-11-2024
- Company Age 51 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,085.77 Cr
as on 19-11-2024
- Satisfied Charges ₹ 4,919.56 Cr
as on 19-11-2024
- Revenue 7.86%
(FY 2024)
- Profit 54.01%
(FY 2024)
- Ebitda 42.72%
(FY 2024)
- Net Worth 12.89%
(FY 2024)
- Total Assets 10.26%
(FY 2024)
About Alkem Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539523 and on the National Stock Exchange(NSE) under ALKEM.
The Corporate was formerly known as Alkem Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 23.91 Cr.
The company currently has active open charges totaling ₹1,085.77 Cr. The company has closed loans amounting to ₹4,919.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alkem Laboratories Limited India are Manish Narang as Company Secretary, Vikas Gupta as Ceo, and Nitin Agrawal as Cfo. Arun Purwar, Narendra Aneja, Basudeo Singh, and Nine other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alkem Laboratories Limited offer?
Alkem Laboratories Limited offers a wide range of products and services, including Medical Consultants & Clinics, Dermatology Treatment Services, Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Test Services, Diabetology Services, Pantoprazole Drugs, Pantoprazole Tablets, Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Alkem Laboratories?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Singh  | Managing Director | 09-Aug-2013 | Current |
| Manish Narang | Company Secretary | 16-Dec-2006 | Current |
| Vikas Gupta | CEO | 22-Sep-2023 | Current |
| Nitin Agrawal | CFO | 16-Feb-2024 | Current |
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujjain Talwar | Director | 05-Aug-2022 | Current |
| Sangeeta Singh | Director | 29-Jun-2015 | Current |
| Rajeev Kher | Director | 07-Sep-2024 | Current |
| Arun Purwar | Director | 16-Mar-2015 | Current |
| Narendra Aneja | Director | 16-Mar-2020 | Current |
| Basudeo Singh | Whole-Time Director | 08-Aug-1973 | Current |
Financial Performance and Corporate Structure Insights of Alkem Laboratories.
Alkem Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.86% increase. The company also saw a substantial improvement in profitability, with a 54.01% increase in profit. The company's net worth Soared by an impressive increase of 12.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alkem Laboratories?
In 2023, Alkem Laboratories had a promoter holding of 57.16% and a public holding of 42.82%. The company had 5 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jul 2024 | ₹100.00 Cr | Open |
Others Creation Date: 26 Feb 2024 | ₹108.00 Cr | Open |
Bank Of India Creation Date: 07 Oct 2023 | ₹85.00 Cr | Open |
How Many Employees Work at Alkem Laboratories?
Alkem Laboratories has a workforce of 18498 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alkem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
